Evidence map›Paper›PMID 39360574›Full record

ArticleCPT: pharmacometrics & systems pharmacology2025

A model-informed clinical trial simulation tool with a graphical user interface for Duchenne muscular dystrophy.

Jongjin Kim, Juan Francisco Morales, Sanghoon Kang, Marian Klose, Rebecca J Willcocks, Michael J Daniels, Ramona Belfiore-Oshan, Glenn A Walter, William D Rooney, Krista Vandenborne and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01484678 (Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01484678 recruitingnot on this map

Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy

TypeobservationalSponsorUniversity of FloridaRan2020 to 2026Enrolled550ConditionsDuchenne Muscular Dystrophy, Becker Muscular Dystrophy
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jongjin KimDepartment of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.ORCID https://orcid.org/0009-0006-0459-8574
Juan Francisco MoralesDepartment of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.ORCID https://orcid.org/0000-0003-1588-9167
Sanghoon KangDepartment of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.ORCID https://orcid.org/0000-0001-6222-7479
Marian KloseDepartment of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.ORCID https://orcid.org/0009-0005-1706-6289
Rebecca J WillcocksDepartment of Physical Therapy, University of Florida, Gainesville, Florida, USA.ORCID https://orcid.org/0000-0003-3383-0759
Michael J DanielsDepartment of Statistics, University of Florida, Gainesville, Florida, USA.ORCID https://orcid.org/0000-0002-9856-9486
Ramona Belfiore-OshanCritical Path Institute, Tucson, Arizona, USA.ORCID https://orcid.org/0000-0003-3380-4972
Glenn A WalterDepartment of Physiology and Aging, University of Florida, Gainesville, Florida, USA.ORCID https://orcid.org/0000-0002-7346-2244
William D RooneyAdvanced Imaging Research Center, Oregon Health & Science University, Portland, Oregon, USA.ORCID https://orcid.org/0000-0003-0617-1540
Krista VandenborneDepartment of Physical Therapy, University of Florida, Gainesville, Florida, USA.ORCID https://orcid.org/0009-0007-8183-1381
Sarah KimDepartment of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.ORCID https://orcid.org/0000-0002-9179-0735

Funding

Magnetic Resonance Imaging and Biomarkers for Muscular DystropyR01AR056973 · NIAMS · UNIVERSITY OF FLORIDA · PI VANDENBORNE, KRISTA H · 2010 to 2024
$20.2M
Optimizing Muscular Dystrophy Clinical Trial Designs using Modeling and SimulationR21TR004006 · NCATS · UNIVERSITY OF FLORIDA · PI KIM, SARAH · 2021 to 2022
$414k
National Institutes of Health (NIH) National Center for Advancing Translational Sciences R21TR004006NCATS NIH HHS R21 TR004006NIAMS NIH HHS R01 AR056973NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases & NIH National Institute of Neurological Disorders and Stroke R01AR056973
6 · The paper itself

Abstract

Quantitative model-based clinical trial simulation tools play a critical role in informing study designs through simulation before actual execution. These tools help drug developers explore various trial scenarios in silico to select a clinical trial design to detect therapeutic effects more efficiently, therefore reducing time, expense, and participants' burden. To increase the usability of the tools, user-friendly and interactive platforms should be developed to navigate various simulation scenarios. However, developing such tools challenges researchers, requiring expertise in modeling and interface development. This tutorial aims to address this gap by guiding developers in creating tailored R Shiny apps, using an example of a model-based clinical trial simulation tool that we developed for Duchenne muscular dystrophy (DMD). In this tutorial, the structural framework, essential controllers, and visualization techniques for analysis are described, along with key code examples such as criteria selection and power calculation. A virtual population was created using a machine learning algorithm to enlarge the available sample size to simulate clinical trial scenarios in the presented tool. In addition, external validation of the simulated outputs was conducted using a placebo arm of a recently published DMD trial. This tutorial will be particularly useful for developing clinical trial simulation tools based on DMD progression models for other end points and biomarkers. The presented strategies can also be applied to other diseases.

Indexed as

Clinical Trials as TopicComputer SimulationMuscular Dystrophy, DuchenneUser-Computer InterfaceAlgorithmsHumansMachine LearningResearch Design

Identifiers

PMID39360574
PMCPMC12625128

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.